Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abivax SA | Paris | Healthcare | Biotechnology & Medical Research | €605.62M | -3x | -1.89 | €9.57 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Valneva | Paris | Healthcare | Biotechnology & Medical Research | €430.28M | -11.2x | 0.04 | €2.65 | 2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genfit | Paris | Healthcare | Biotechnology & Medical Research | €264.98M | 11.9x | 0.07 | €5.32 | 2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Eurobio Scientific | Paris | Healthcare | Biotechnology & Medical Research | €260.13M | 43.1x | -1.74 | €25.90 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.8% Upside | Upgrade to Pro+ | |
Ose Pharma International SA | Paris | Healthcare | Biotechnology & Medical Research | €217.32M | 4.6x | 0.02 | €9.99 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.2% Upside | Upgrade to Pro+ | |
Inventiva | Paris | Healthcare | Biotechnology & Medical Research | €215.08M | -1.2x | 0.23 | €2.46 | -4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sensorion SA | Paris | Healthcare | Biotechnology & Medical Research | €209.65M | -6.7x | -0.15 | €0.70 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nanobiotix | Paris | Healthcare | Biotechnology & Medical Research | €185.83M | -5x | -0.11 | €3.92 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cellectis | Paris | Healthcare | Biotechnology & Medical Research | €171.16M | -1.7x | -0.06 | €1.71 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Adocia | Paris | Healthcare | Biotechnology & Medical Research | €147.49M | -6.3x | -0.19 | €9.71 | 6.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -30.8% Downside | Upgrade to Pro+ | |
Innate Pharma | Paris | Healthcare | Biotechnology & Medical Research | €137.62M | -4x | -0.09 | €1.70 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Transgene | Paris | Healthcare | Biotechnology & Medical Research | €118.92M | -4x | -0.15 | €0.90 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Maat Pharma | Paris | Healthcare | Biotechnology & Medical Research | €102.16M | -3.7x | 0.09 | €7.34 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Eurofins-Cerep | Paris | Healthcare | Biotechnology & Medical Research | €97.35M | 9.9x | €19,300 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Novacyt | Paris | Healthcare | Biotechnology & Medical Research | €46.92M | -1x | 0.02 | €0.67 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Abionyx Pharma SA | Paris | Healthcare | Biotechnology & Medical Research | €42.65M | -11.5x | -0.56 | €1.23 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Gensight Biologics | Paris | Healthcare | Biotechnology & Medical Research | €33.25M | -1x | -0.03 | €0.31 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20% Upside | Upgrade to Pro+ | |
Fermentalg | Paris | Healthcare | Biotechnology & Medical Research | €30.36M | -1.3x | 0.14 | €0.35 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genoway | Paris | Healthcare | Biotechnology & Medical Research | €30.28M | 22.7x | €3.36 | -3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Oncodesign Precision Medicine | Paris | Healthcare | Biotechnology & Medical Research | €21.98M | -2.3x | €1.15 | -5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
NFL Biosciences | Paris | Healthcare | Biotechnology & Medical Research | €20.62M | €2.16 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Valbiotis | Paris | Healthcare | Biotechnology & Medical Research | €20.23M | -2.2x | -0.06 | €1.28 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Phaxiam Therapeutics | Paris | Healthcare | Biotechnology & Medical Research | €16.64M | -0.3x | €1.66 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Plant Advanced Technologies SA | Paris | Healthcare | Biotechnology & Medical Research | €16.18M | 187.6x | €14.60 | 2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Poxel SA | Paris | Healthcare | Biotechnology & Medical Research | €14.92M | -0.3x | -0.18 | €0.28 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Predilife | Paris | Healthcare | Biotechnology & Medical Research | €13.68M | -3.2x | 0.22 | €3.68 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
TME Pharma NV | Paris | Healthcare | Biotechnology & Medical Research | €6.71M | -0.4x | -0.01 | €0.16 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Acticor Biotech | Paris | Healthcare | Biotechnology & Medical Research | €6.28M | -0.3x | 0.15 | €0.36 | -10% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Quantum Genomics SA | Paris | Healthcare | Biotechnology & Medical Research | €5.03M | -0.8x | -0.02 | €0.07 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 38.7% Upside | Upgrade to Pro+ | |
Theranexus | Paris | Healthcare | Biotechnology & Medical Research | €3.96M | -1.3x | -0.02 | €0.51 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |